Literature DB >> 8126113

Molecular mechanisms of neural crest cell attachment and migration on types I and IV collagen.

R Perris1, J Syfrig, M Paulsson, M Bronner-Fraser.   

Abstract

We have examined the mechanisms involved in the interaction of avian neural crest cells with collagen types I and IV (Col I and IV) during their adhesion and migration in vitro. For this purpose native Col IV was purified from chicken tissues, characterized biochemically and ultrastructurally. Purified chicken Col I and Col IV, and various proteolytic fragments of the collagens, were used in quantitative cell attachment and migration assays in conjunction with domain-specific collagen antibodies and antibodies to avian integrin subunits. Neural crest cells do not distinguish between different macromolecular arrangements of Col I during their initial attachment, but do so during their migration, showing a clear preference for polymeric Col I. Interaction with Col I is mediated by the alpha 1 beta 1 integrin, through binding to a segment of the alpha 1(I) chain composed of fragment CNBr3. Neural crest cell attachment and migration on Col IV involves recognition of conformation-dependent sites within the triple-helical region and the noncollagenous, carboxyl-terminal NC1 domain. This recognition requires integrity of inter- and intrachain disulfide linkages and correct folding of the molecule. Moreover, there also is evidence that interaction sites within the NC1 domain may be cryptic, being exposed during migration of the cells in the intact collagen as a result of the prolonged cell-substratum contact. In contrast to Col I, neural crest cell interaction with Col IV is mediated by beta 1-class integrins other than alpha 1 beta 1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8126113     DOI: 10.1242/jcs.106.4.1357

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  9 in total

Review 1.  New functional roles for non-collagenous domains of basement membrane collagens.

Authors:  Nathalie Ortega; Zena Werb
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

2.  Primary culture of chick, mouse or human neural crest cells.

Authors:  Heather Etchevers
Journal:  Nat Protoc       Date:  2011-09-22       Impact factor: 13.491

Review 3.  Role of the extracellular matrix in neural crest cell migration.

Authors:  D J Henderson; A J Copp
Journal:  J Anat       Date:  1997-11       Impact factor: 2.610

4.  Extracellular matrix-regulated neural differentiation of human multipotent marrow progenitor cells enhances functional recovery after spinal cord injury.

Authors:  Win-Ping Deng; Chi-Chiang Yang; Liang-Yo Yang; Chun-Wei D Chen; Wei-Hong Chen; Charn-Bing Yang; Yu-Hsin Chen; Wen-Fu T Lai; Perry F Renshaw
Journal:  Spine J       Date:  2014-04-30       Impact factor: 4.166

5.  CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes.

Authors:  J R Knutson; J Iida; G B Fields; J B McCarthy
Journal:  Mol Biol Cell       Date:  1996-03       Impact factor: 4.138

Review 6.  Mammalian collagen IV.

Authors:  Jamshid Khoshnoodi; Vadim Pedchenko; Billy G Hudson
Journal:  Microsc Res Tech       Date:  2008-05       Impact factor: 2.769

7.  A neural crest cell isotropic-to-nematic phase transition in the developing mammalian gut.

Authors:  Nicolas R Chevalier; Yanis Ammouche; Anthony Gomis; Lucas Langlois; Thomas Guilbert; Pierre Bourdoncle; Sylvie Dufour
Journal:  Commun Biol       Date:  2021-06-23

8.  Specific roles of the alpha V beta 1, alpha V beta 3 and alpha V beta 5 integrins in avian neural crest cell adhesion and migration on vitronectin.

Authors:  M Delannet; F Martin; B Bossy; D A Cheresh; L F Reichardt; J L Duband
Journal:  Development       Date:  1994-09       Impact factor: 6.868

Review 9.  Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression.

Authors:  Akulapalli Sudhakar; Chandra S Boosani
Journal:  Pharm Res       Date:  2008-06-13       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.